401 related articles for article (PubMed ID: 17289807)
21. Identification of mutations in SLC40A1 that affect ferroportin function and phenotype of human ferroportin iron overload.
Mayr R; Griffiths WJ; Hermann M; McFarlane I; Halsall DJ; Finkenstedt A; Douds A; Davies SE; Janecke AR; Vogel W; Cox TM; Zoller H
Gastroenterology; 2011 Jun; 140(7):2056-63, 2063.e1. PubMed ID: 21396368
[TBL] [Abstract][Full Text] [Related]
22. A novel SLC40A1 p.Y333H mutation with gain of function of ferroportin: A recurrent cause of haemochromatosis in China.
Zhang W; Xu A; Li Y; Zhao S; Zhou D; Wu L; Zhang B; Zhao X; Wang Y; Wang X; Duan W; Wang Q; Nan Y; You H; Jia J; Ou X; Huang J;
Liver Int; 2019 Jun; 39(6):1120-1127. PubMed ID: 30500107
[TBL] [Abstract][Full Text] [Related]
23. Estrogen contributes to regulating iron metabolism through governing ferroportin signaling via an estrogen response element.
Qian Y; Yin C; Chen Y; Zhang S; Jiang L; Wang F; Zhao M; Liu S
Cell Signal; 2015 May; 27(5):934-42. PubMed ID: 25660146
[TBL] [Abstract][Full Text] [Related]
24. Impact of D181V and A69T on the function of ferroportin as an iron export pump and hepcidin receptor.
Praschberger R; Schranz M; Griffiths WJ; Baumgartner N; Hermann M; Lomas DJ; Pietrangelo A; Cox TM; Vogel W; Zoller H
Biochim Biophys Acta; 2014 Sep; 1842(9):1406-12. PubMed ID: 24859227
[TBL] [Abstract][Full Text] [Related]
25. Ferroportin-1 is a 'nuclear'-negative acute-phase protein in rat liver: a comparison with other iron-transport proteins.
Naz N; Malik IA; Sheikh N; Ahmad S; Khan S; Blaschke M; Schultze F; Ramadori G
Lab Invest; 2012 Jun; 92(6):842-56. PubMed ID: 22469696
[TBL] [Abstract][Full Text] [Related]
26. Resistance of ferroportin to hepcidin binding causes exocrine pancreatic failure and fatal iron overload.
Altamura S; Kessler R; Gröne HJ; Gretz N; Hentze MW; Galy B; Muckenthaler MU
Cell Metab; 2014 Aug; 20(2):359-67. PubMed ID: 25100063
[TBL] [Abstract][Full Text] [Related]
27. Mice with hepcidin-resistant ferroportin accumulate iron in the retina.
Theurl M; Song D; Clark E; Sterling J; Grieco S; Altamura S; Galy B; Hentze M; Muckenthaler MU; Dunaief JL
FASEB J; 2016 Feb; 30(2):813-23. PubMed ID: 26506980
[TBL] [Abstract][Full Text] [Related]
28. Leishmania-mediated inhibition of iron export promotes parasite replication in macrophages.
Ben-Othman R; Flannery AR; Miguel DC; Ward DM; Kaplan J; Andrews NW
PLoS Pathog; 2014 Jan; 10(1):e1003901. PubMed ID: 24497831
[TBL] [Abstract][Full Text] [Related]
29. Myeloid-specific deletion of ferroportin impairs macrophage bioenergetics but is disconnected from systemic insulin action in adult mice.
Winn NC; Wolf EM; Cottam MA; Bhanot M; Hasty AH
Am J Physiol Endocrinol Metab; 2021 Sep; 321(3):E376-E391. PubMed ID: 34338042
[TBL] [Abstract][Full Text] [Related]
30. Molecular and clinical correlates in iron overload associated with mutations in ferroportin.
De Domenico I; McVey Ward D; Nemeth E; Ganz T; Corradini E; Ferrara F; Musci G; Pietrangelo A; Kaplan J
Haematologica; 2006 Aug; 91(8):1092-5. PubMed ID: 16885049
[TBL] [Abstract][Full Text] [Related]
31. Characterization of three novel pathogenic SLC40A1 mutations and genotype/phenotype correlations in 7 Italian families with type 4 hereditary hemochromatosis.
Majore S; Bonaccorsi di Patti MC; Valiante M; Polticelli F; Cortese A; Di Bartolomeo S; De Bernardo C; De Muro M; Faienza F; Radio FC; Grammatico P; Musci G
Biochim Biophys Acta Mol Basis Dis; 2018 Feb; 1864(2):464-470. PubMed ID: 29154924
[TBL] [Abstract][Full Text] [Related]
32. Clinical presentation and molecular pathophysiology of autosomal dominant hemochromatosis caused by a novel ferroportin mutation.
Griffiths WJ; Mayr R; McFarlane I; Hermann M; Halsall DJ; Zoller H; Cox TM
Hepatology; 2010 Mar; 51(3):788-95. PubMed ID: 19937651
[TBL] [Abstract][Full Text] [Related]
33. A disease-causing mutation K240E disrupts ferroportin trafficking by SUMO (ferroportin SUMOylation).
Bayele HK; Srai SKS
Biochem Biophys Rep; 2021 Mar; 25():100873. PubMed ID: 33490642
[TBL] [Abstract][Full Text] [Related]
34. Long-term phlebotomy successfully alleviated hepatic iron accumulation in a ferroportin disease patient with a mutation in SLC40A1: a case report.
Nishina S; Tomiyama Y; Ikuta K; Tatsumi Y; Toki Y; Kato A; Kato K; Yoshioka N; Sasaki K; Hara Y; Hino K
BMC Gastroenterol; 2021 Mar; 21(1):111. PubMed ID: 33673803
[TBL] [Abstract][Full Text] [Related]
35. Zebrafish as a model for defining the functional impact of mammalian ferroportin mutations.
De Domenico I; Vaughn MB; Yoon D; Kushner JP; Ward DM; Kaplan J
Blood; 2007 Nov; 110(10):3780-3. PubMed ID: 17726163
[TBL] [Abstract][Full Text] [Related]
36. The dynamics of hepcidin-ferroportin internalization and consequences of a novel ferroportin disease mutation.
Wallace DF; McDonald CJ; Ostini L; Iser D; Tuckfield A; Subramaniam VN
Am J Hematol; 2017 Oct; 92(10):1052-1061. PubMed ID: 28681497
[TBL] [Abstract][Full Text] [Related]
37. The Role of Copper in the Regulation of Ferroportin Expression in Macrophages.
Jończy A; Mazgaj R; Smuda E; Żelazowska B; Kopeć Z; Starzyński RR; Lipiński P
Cells; 2021 Aug; 10(9):. PubMed ID: 34571908
[TBL] [Abstract][Full Text] [Related]
38. miR-20a regulates expression of the iron exporter ferroportin in lung cancer.
Babu KR; Muckenthaler MU
J Mol Med (Berl); 2016 Mar; 94(3):347-59. PubMed ID: 26560875
[TBL] [Abstract][Full Text] [Related]
39. Ferroportin-mediated iron export from vascular endothelial cells in retina and brain.
Baumann BH; Shu W; Song Y; Simpson EM; Lakhal-Littleton S; Dunaief JL
Exp Eye Res; 2019 Oct; 187():107728. PubMed ID: 31323276
[TBL] [Abstract][Full Text] [Related]
40. Expression of hepcidin and ferroportin in full term placenta of pregnant cows.
Roperto S; Russo V; Urraro C; Cutarelli A; Perillo A; De Falco F; Roperto F
Theriogenology; 2017 Nov; 103():90-97. PubMed ID: 28780484
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
